- Report
- June 2024
- 200 Pages
Global
From €7587EUR$7,950USD£6,357GBP
- Report
- March 2025
- 185 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- September 2024
- 250 Pages
Global
From €4723EUR$4,949USD£3,957GBP
- Report
- July 2023
- 90 Pages
United States
From €2147EUR$2,250USD£1,799GBP
- Report
- October 2023
- 177 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- August 2023
- 112 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- July 2023
- 77 Pages
Egypt
From €3340EUR$3,500USD£2,799GBP
- Report
- February 2024
- 244 Pages
Global
From €7587EUR$7,950USD£6,357GBP
- Report
- January 2024
- 200 Pages
Global
From €7587EUR$7,950USD£6,357GBP
- Book
- November 2018
- 464 Pages

Retinal degeneration is a group of eye diseases that cause progressive damage to the retina, the light-sensitive tissue at the back of the eye. It is a major cause of vision loss and blindness in adults. Symptoms of retinal degeneration include blurred vision, difficulty seeing in dim light, and blind spots in the field of vision. Treatment options include laser therapy, photodynamic therapy, and retinal implants.
Optical treatments for retinal degeneration include the use of corrective lenses, such as glasses or contact lenses, to improve vision. Surgery may also be used to correct vision problems caused by retinal degeneration. In addition, optical coherence tomography (OCT) is a non-invasive imaging technique used to diagnose and monitor retinal degeneration.
Companies in the retinal degeneration market include Alcon, Bausch + Lomb, Carl Zeiss Meditec, Heidelberg Engineering, Optovue, Topcon, and Zeiss. Show Less Read more